Metabolic and cardiovascular effects of early insulin glargin prescription: based on data from ORIGIN study

We discuss results of ORIGIN, a multicenter parallel groups study for efficiency assessment of insulin glargin against polyunsaturatedomega-3 fatty acids or placebo regarding cardiovascular and/or mortality risk reduction in patients with impaired fasting glycemia,impaired glucose tolerance or type...

Full description

Bibliographic Details
Main Authors: Elena Valer'evna Biryukova, Alexander Sergeevich Ametov, Mikhail Borisovich Antsiferov, Alsu Gafurovna Zalevskaya, Galina Afanas'evna Mel'nichenko, Ashot Musaelovich Mkrtumyan, Marina Vladimirovna Shestakova
Format: Article
Language:English
Published: Endocrinology Research Centre 2012-09-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/6092